Fifty years ago, researchers from Beecham Pharmaceuticals reported on the structure of clavulanic acid. Itself only a weak antibiotic, clavulanic acid inhibits serine β-lactamases and thus this work pioneered combination therapy to protect antibiotics against the development of resistance.
- Andrew V. Stachulski
- Christopher J. Schofield